These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28087278)

  • 1. Prolyl-tRNA synthetase inhibition promotes cell death in SK-MEL-2 cells through GCN2-ATF4 pathway activation.
    Arita T; Morimoto M; Yamamoto Y; Miyashita H; Kitazawa S; Hirayama T; Sakamoto S; Miyamoto K; Adachi R; Iwatani M; Hara T
    Biochem Biophys Res Commun; 2017 Jul; 488(4):648-654. PubMed ID: 28087278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel prolyl-tRNA synthetase inhibitor and elucidation of its binding mode to the ATP site in complex with l-proline.
    Adachi R; Okada K; Skene R; Ogawa K; Miwa M; Tsuchinaga K; Ohkubo S; Henta T; Kawamoto T
    Biochem Biophys Res Commun; 2017 Jun; 488(2):393-399. PubMed ID: 28501621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoacyl-tRNA synthetase inhibition activates a pathway that branches from the canonical amino acid response in mammalian cells.
    Kim Y; Sundrud MS; Zhou C; Edenius M; Zocco D; Powers K; Zhang M; Mazitschek R; Rao A; Yeo CY; Noss EH; Brenner MB; Whitman M; Keller TL
    Proc Natl Acad Sci U S A; 2020 Apr; 117(16):8900-8911. PubMed ID: 32253314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.
    Lv PC; Zhu HL
    Curr Med Chem; 2012; 19(21):3550-63. PubMed ID: 22680640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma.
    De Monte C; Carradori S; Secci D; D'Ascenzio M; Guglielmi P; Mollica A; Morrone S; Scarpa S; Aglianò AM; Giantulli S; Silvestri I
    Eur J Med Chem; 2015 Nov; 105():245-62. PubMed ID: 26498571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia.
    Habibi D; Ogloff N; Jalili RB; Yost A; Weng AP; Ghahary A; Ong CJ
    Invest New Drugs; 2012 Aug; 30(4):1361-70. PubMed ID: 21678129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase.
    Keller TL; Zocco D; Sundrud MS; Hendrick M; Edenius M; Yum J; Kim YJ; Lee HK; Cortese JF; Wirth DF; Dignam JD; Rao A; Yeo CY; Mazitschek R; Whitman M
    Nat Chem Biol; 2012 Feb; 8(3):311-7. PubMed ID: 22327401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy.
    Shibata A; Kuno M; Adachi R; Sato Y; Hattori H; Matsuda A; Okuzono Y; Igaki K; Tominari Y; Takagi T; Yabuki M; Okaniwa M
    PLoS One; 2017; 12(10):e0186587. PubMed ID: 29065190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agent.
    Cersosimo U; Sgorbissa A; Foti C; Drioli S; Angelica R; Tomasella A; Picco R; Semrau MS; Storici P; Benedetti F; Berti F; Brancolini C
    J Med Chem; 2015 Feb; 58(4):1691-704. PubMed ID: 25639862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents.
    Ma LY; Zheng YC; Wang SQ; Wang B; Wang ZR; Pang LP; Zhang M; Wang JW; Ding L; Li J; Wang C; Hu B; Liu Y; Zhang XD; Wang JJ; Wang ZJ; Zhao W; Liu HM
    J Med Chem; 2015 Feb; 58(4):1705-16. PubMed ID: 25610955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review.
    Bouz G; Zitko J
    Bioorg Chem; 2021 May; 110():104806. PubMed ID: 33799176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel potent migrastatic Thiazolo[5,4-b]pyridines targeting Lysyl-tRNA synthetase (KRS) for treatment of Cancer metastasis.
    Lee S; Kwon NH; Seo B; Lee JY; Cho HY; Kim K; Kim HS; Jung K; Jeon YH; Kim S; Suh YG
    Eur J Med Chem; 2021 Jun; 218():113405. PubMed ID: 33831781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway.
    Wang SF; Chen MS; Chou YC; Ueng YF; Yin PH; Yeh TS; Lee HC
    Oncotarget; 2016 Nov; 7(45):74132-74151. PubMed ID: 27708226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiophene-3-carboxamide analogue of annonaceous acetogenins as antitumor drug lead.
    Kojima N; Fushimi T; Tatsukawa T; Tanaka T; Okamura M; Akatsuka A; Yamori T; Dan S; Iwasaki H; Yamashita M
    Eur J Med Chem; 2014 Oct; 86():684-9. PubMed ID: 25226228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biological Evaluation of Novel 4-(4-Formamidophenylamino)-
    Meng N; Zhou S; Hu M; Xu Y; Xia Y; Zeng X; Yu L
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Leucyladenylate Sulfamates as Novel Leucyl-tRNA Synthetase (LRS)-Targeted Mammalian Target of Rapamycin Complex 1 (mTORC1) Inhibitors.
    Yoon S; Kim JH; Kim SE; Kim C; Tran PT; Ann J; Koh Y; Jang J; Kim S; Moon HS; Kim WK; Lee S; Lee J; Kim S; Lee J
    J Med Chem; 2016 Nov; 59(22):10322-10328. PubMed ID: 27933890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor.
    Hu J; Wang Y; Li Y; Xu L; Cao D; Song S; Damaneh MS; Wang X; Meng T; Chen YL; Shen J; Miao Z; Xiong B
    Eur J Med Chem; 2017 Sep; 137():176-195. PubMed ID: 28586718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of bis-aryl ureas and amides based on 2-amino-3-purinylpyridine scaffold as DFG-out B-Raf kinase inhibitors.
    Yang W; Chen Y; Zhou X; Gu Y; Qian W; Zhang F; Han W; Lu T; Tang W
    Eur J Med Chem; 2015 Jan; 89():581-96. PubMed ID: 25462267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C/ebp-Atf response element (CARE) location reveals two distinct Atf4-dependent, elongation-mediated mechanisms for transcriptional induction of aminoacyl-tRNA synthetase genes in response to amino acid limitation.
    Shan J; Zhang F; Sharkey J; Tang TA; Örd T; Kilberg MS
    Nucleic Acids Res; 2016 Nov; 44(20):9719-9732. PubMed ID: 27471030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
    Bindi S; Fancelli D; Alli C; Berta D; Bertrand JA; Cameron AD; Cappella P; Carpinelli P; Cervi G; Croci V; D'Anello M; Forte B; Giorgini ML; Marsiglio A; Moll J; Pesenti E; Pittalà V; Pulici M; Riccardi-Sirtori F; Roletto F; Soncini C; Storici P; Varasi M; Volpi D; Zugnoni P; Vianello P
    Bioorg Med Chem; 2010 Oct; 18(19):7113-20. PubMed ID: 20817473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.